Shire Adderall XR Sales Suspended In Canada; FDA Stands By "Black Box"
This article was originally published in The Pink Sheet Daily
Executive Summary
Company plans a "Dear Doctor" letter informing U.S. physicians of Health Canada's decision. FDA says it "has not decided to take any further regulatory action at this time"; sudden death warnings were added to Adderall XR's labeling in August.